Avacta and Selexis Partner to Develop Cell Line for Clinical Manufacturing
Avacta’s first Affimer clinical candidate is a potent PD-L1 antagonist under development for solid tumor indications as the basis of bispecific and combination therapies
Avacta’s first Affimer clinical candidate is a potent PD-L1 antagonist under development for solid tumor indications as the basis of bispecific and combination therapies
High-throughput screening, antibody labeling, bispecific studies and more
SelectScience attended this year’s AAI IMMUNOLOGY conference to bring you the latest news and technology in the field
From lightning-fast labeling technology to real-time cytometry and high-throughput protein interaction analysis, find out what technologies are making the headlines in life sciences this month
As the global antibody market hits new heights, meet one scientist working to bridge the gap between biomarker discovery and antibody development with high-speed phage-display technology
Find all the latest developments and top content in our drug discovery community over the past month
Join this webinar to learn more about the new generation of therapeutic antibodies and find out how solutions from Sartorius can be used to accelerate their identification
Expedeon’s technology directly conjugates antibodies to enzymes, small molecules and fluorescent dyes
Real-time, live-cell imaging and analysis tools for effective antibody characterization
New isotype-specific secondary antibodies promise improved signal detection and specificity in imaging
A crosstalk-free 7-plex immunostaining method using widefield fluorescence microscopy shows promise for the detection of early-stage prostate cancer prediction
Partnership will develop conjugated FFPE IHC validated antibodies that are compatible with the GeoMx Digital Spatial Profiler
New range for use in drug level monitoring assays and biosimilar development
Dr. David Baker, Mimi Roy, Promega and Thermo Fisher Scientific among those recognized in Washington, D.C., for their parts in advancing the drug discovery and development
Relive the biggest stories of the month and find out what’s been making waves in the SelectScience life sciences community since the turn of the year
Published in the peer-reviewed journal mAbs, the paper introduces complex-specific antibodies for pharmacokinetic analysis of biotherapeutics
Global Meningococcal Initiative warns of growing worldwide threat of resistance to traditional antibiotics
Just leave a quick lab product review today for your chance to scoop the $100 Grand Prize this week
Scientists across the world share their thoughts on the benefits of reading reviews on SelectScience
In their tenth anniversary year, The Scientists’ Choice Awards saw more scientists and top technologies recognized than ever before
Learn how to choose the best types of antibody for your application, plus discover top tips for antigen and antibody optimization and validation
Receive your 4 free cancer pathway posters for MAPK, NF-ƘB, WNT and JAK/STAT, to help you select the best antibodies and small molecules for your cancer research assays